CA2415345A1 - Linkage of agents using microparticles - Google Patents

Linkage of agents using microparticles Download PDF

Info

Publication number
CA2415345A1
CA2415345A1 CA002415345A CA2415345A CA2415345A1 CA 2415345 A1 CA2415345 A1 CA 2415345A1 CA 002415345 A CA002415345 A CA 002415345A CA 2415345 A CA2415345 A CA 2415345A CA 2415345 A1 CA2415345 A1 CA 2415345A1
Authority
CA
Canada
Prior art keywords
agent
polymer
microparticle
kit
transglutaminase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002415345A
Other languages
English (en)
French (fr)
Inventor
Howard Green
Bruce J. Compton
George D. Corey
Philippe Djian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pericor Science Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2415345A1 publication Critical patent/CA2415345A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/94—Involves covalent bonding to the substrate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CA002415345A 2000-07-21 2001-07-19 Linkage of agents using microparticles Abandoned CA2415345A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/620,783 US6958148B1 (en) 1998-01-20 2000-07-21 Linkage of agents to body tissue using microparticles and transglutaminase
US09/620,783 2000-07-21
PCT/US2001/022681 WO2002007707A2 (en) 2000-07-21 2001-07-19 Linkage of agents using microparticles

Publications (1)

Publication Number Publication Date
CA2415345A1 true CA2415345A1 (en) 2002-01-31

Family

ID=24487368

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002415345A Abandoned CA2415345A1 (en) 2000-07-21 2001-07-19 Linkage of agents using microparticles

Country Status (6)

Country Link
US (2) US6958148B1 (enExample)
EP (1) EP1303260A2 (enExample)
JP (1) JP2004504340A (enExample)
AU (1) AU2002224524A1 (enExample)
CA (1) CA2415345A1 (enExample)
WO (1) WO2002007707A2 (enExample)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69310339T2 (de) 1993-02-19 1997-08-21 Philippe Djian Präparate, die Corneozyt Proteine enthalten
US6958148B1 (en) * 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6821509B2 (en) * 2000-04-14 2004-11-23 Cosmetica, Inc. Nanoscopic hair care products
GB0115320D0 (en) 2001-06-22 2001-08-15 Univ Nottingham Matrix
AU2002336533B2 (en) * 2001-09-13 2007-04-26 Ansell Healthcare Products Llc Microencapsulation coating for gloves
FR2838640B1 (fr) * 2002-04-19 2006-02-24 Oreal Composition cosmetique comprenant un actif cosmetique et un systeme ligand-recepteur exogene fixe de facon covalente aux cheveux et procede de traitement des cheveux utilisant cette composition
CN1671400A (zh) * 2002-07-03 2005-09-21 派瑞克科学公司 透明质酸组合物以及使用方法
MY140194A (en) * 2003-07-16 2009-11-30 Leo Pharma As Novel fusidic acid derivatives
US7309482B2 (en) * 2003-09-08 2007-12-18 E.I. Du Pont De Nemours And Company Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner
FR2870741B1 (fr) * 2004-05-25 2008-03-14 Coletica Sa Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant.
JP2009504661A (ja) * 2005-08-09 2009-02-05 ソーン・ラブズ・エルエルシー ヘアホールド配合物
AR059601A1 (es) * 2006-02-21 2008-04-16 Mary Kay Inc Composiciones estables de vitamina c
US20070225213A1 (en) * 2006-03-23 2007-09-27 Kosak Matthew K Nucleic acid carriers for delivery of therapeutic agents
US20080145323A1 (en) * 2006-09-07 2008-06-19 Epiderma Pet, Llc Formulation and method for a sunblock for animals
JPWO2008056623A1 (ja) * 2006-11-09 2010-02-25 第一三共株式会社 核酸導入用組成物
CA2726420C (en) * 2007-06-01 2018-07-31 Chx Technologies, Inc. Topical dental solution of chlorhexidine in sumatra benzoin bp/ep and methods of manufacturing and evaluating same for compliance with international regulatory specifications
US20100173147A1 (en) * 2007-06-22 2010-07-08 Steven Greenland Cationic, Energy-Cured Varnish With Microcapsules
US8029771B2 (en) * 2007-06-29 2011-10-04 Mary Kay Inc. Guar gum containing compounds
FR2918271B1 (fr) * 2007-07-03 2009-11-13 Oreal Composition cosmetique associant un polymere silicone et une resine tackifiante, et presentant une certaine elasticite
EP2022467A1 (en) * 2007-08-07 2009-02-11 KPSS-Kao Professional Salon Services GmbH Two-phase composition for conditioning hair
US20090175945A1 (en) * 2008-01-08 2009-07-09 Jie Zhang Systems, Methods, and Formulations for Topically Treating Nail Fungal Infections and Nail Psoriasis
US20090202581A1 (en) * 2008-02-12 2009-08-13 Nathalie Schlemer Cosmetic formulation
EP2276420B1 (en) 2008-04-04 2021-10-06 Journey1, Inc. Device to treat an eye having an epithelium with a defect
EP2355785A4 (en) 2008-12-09 2014-08-13 Oréal Sa L TRANSFER SOLID EMULSION WITH A TENSID
WO2010077940A2 (en) 2008-12-16 2010-07-08 Hy Si Bui Water-insoluble reaction product of a polyamine and an oil-soluble high carbon polar modified polymer
WO2010077887A2 (en) 2008-12-16 2010-07-08 L'oreal S.A Transfer-resistant and long wear foundation in emulsion form containing oil absorbing powders
CN102395378B (zh) 2009-02-18 2016-01-20 爱昂粒子科学有限责任公司 用于眼科和其他外用或局部应用的双功能共聚物
EP2236520A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Stabilizing composition for immobilized biomolecules
CA2760554A1 (en) * 2009-05-01 2010-11-04 Signal Investment And Management Co. Moisturizing antimicrobial composition
US8253309B2 (en) * 2009-06-24 2012-08-28 Cunningham David W Incandescent lamp incorporating reflective filament supports and method for making it
US8828366B2 (en) * 2009-06-29 2014-09-09 L'oreal Hydrating cream foundation in emulsion form
EP2305210A3 (en) * 2009-06-29 2011-04-13 L'oreal S.A. Composition comprising a sugar silicone surfactant and an oil-soluble polar modified polymer
WO2011008540A2 (en) 2009-06-29 2011-01-20 L'oreal S.A Refreshing cream foundation in gel form
EP2322248B1 (en) 2009-06-29 2017-12-27 L'oreal S.A. Composition comprising a polyol and an oil-soluble polar modified polymer
BRPI1002597A2 (pt) * 2009-06-29 2012-03-13 L'oreal S.A. Composição que compreende pelo menos um polímero polar modificado solúvel em óleo
BRPI1002598A2 (pt) * 2009-06-29 2012-03-13 L'oreal S.A. Composição e método para a maquilagem dos cílios
US8647611B2 (en) 2009-06-29 2014-02-11 L'oréal Composition containing a polyol and a reaction product
US8470304B2 (en) 2009-08-04 2013-06-25 Avidas Pharmaceuticals Llc Therapeutic vitamin D sun-protecting formulations and methods for their use
US9498385B2 (en) 2009-10-23 2016-11-22 Nexisvision, Inc. Conformable therapeutic shield for vision and pain
ES2649890T3 (es) 2009-10-23 2018-01-16 Nexisvision, Inc. Enervación corneal para el tratamiento de dolor ocular
EA015599B1 (ru) * 2009-11-11 2011-10-31 Открытое Акционерное Общество "Верофарм" Косметические средства, обладающие противомикробными свойствами
CN102781404B (zh) * 2010-02-04 2014-08-27 Isp投资公司 用于无水遮光剂配制物的自适应聚合物
US20170260235A1 (en) 2010-04-27 2017-09-14 Chanel Parfums Beaute Polypeptide expressed in the stratum corneum and use thereof
FR2959230B1 (fr) * 2010-04-27 2016-03-25 Chanel Parfums Beaute Polypeptide exprime dans la couche cornee et son utilisation
US20110280818A1 (en) * 2010-05-14 2011-11-17 L'oreal S.A. Compositions containing hyperbranched polyol and tackifier
PL2654474T3 (pl) * 2010-12-22 2016-06-30 Avon Prod Inc Kosmetyczna kompozycja adhezyjna
US8747868B2 (en) 2010-12-30 2014-06-10 L'oreal Reaction product of a polar modified polymer and an alkoxysilane and a composition containing the reaction product
US20120237466A1 (en) * 2011-03-18 2012-09-20 James Graham Photo-filtering composition for hair and scalp
EP2696677B1 (en) 2011-04-13 2021-08-11 BioSafe Technologies, Inc. Insecticide, insect repellant and anti-irritation composition
US12044905B2 (en) 2011-04-28 2024-07-23 Journey1 Inc Contact lenses for refractive correction
DE102011087320A1 (de) * 2011-11-29 2013-05-29 Henkel Ag & Co. Kgaa Neuartige Wirkstoffkombination zur effizienten Anti-Faltenwirkung
US8992895B2 (en) * 2012-12-19 2015-03-31 L'oreal Sunscreen compositions
EP2941243A4 (en) 2013-01-04 2016-09-14 Massachusetts Inst Technology SURFACE BINDING IN THE ADMINISTRATION OF A MEDICAMENT ON NANOPARTICLE BASE IN A TISSUE
JP6310072B2 (ja) 2013-06-26 2018-04-11 ネクシスビジョン， インコーポレイテッド 屈折矯正のためのコンタクトレンズ
CN105593238B (zh) 2013-07-11 2020-09-08 诺华股份有限公司 使用微生物转谷氨酰胺酶进行赖氨酸特异性化学酶法蛋白质修饰
EP3065717A1 (en) * 2013-11-04 2016-09-14 Biopharmx, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
CN103655335B (zh) * 2013-12-11 2016-03-02 彭再辉 一种儿童洗发沐浴二合一组合物
US20160051723A1 (en) * 2014-08-21 2016-02-25 Gregory J. Pomrink Bioresorbable tissue repair composition
US20180206960A1 (en) * 2015-07-22 2018-07-26 Cao Group, Inc. Dental treatment films incorporating unmixed reactive ingredients
CA3050082A1 (en) 2016-04-04 2017-10-12 Omeza LLC Fish oil topical composition
CA3029391C (en) 2016-07-06 2024-01-02 Eyeon Particle Sciences Llc Bi-functional co-polymer use for ophthalmic and other topical and local applications
US10085926B2 (en) * 2017-01-26 2018-10-02 Anise Cosmetics, LLC Nail polish remover compositions and methods
US10433554B2 (en) 2017-05-01 2019-10-08 Ohio State Innovation Foundation Deodorizing compounds, compositions, and methods for repelling insects
WO2020018888A1 (en) 2018-07-20 2020-01-23 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use
WO2024145694A1 (en) * 2022-12-30 2024-07-04 Steuben Foods, Inc. Hydrolysate compositions and methods for producing thereof

Family Cites Families (330)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867365A (en) 1970-08-05 1975-02-18 Kremers Urban Co Penicilloyl-polylysine conjugates having dextro-rotary optical activity, and methods for their preparation and use
LU65552A1 (enExample) 1972-06-20 1973-12-27
US3979508A (en) 1972-07-24 1976-09-07 Kremers-Urban Company Compositions and methods therewith for penicillin hypersensitivity detection
LU72593A1 (enExample) 1975-05-28 1977-02-10
JPS5835520B2 (ja) 1976-06-01 1983-08-03 株式会社第一ラジオアイソト−プ研究所 ６−カルボキシメチルチオコルチゾ−ルおよびその誘導体
US4152411A (en) 1977-07-27 1979-05-01 Akzona Incorporated High specific activity labeled substances
US4357259A (en) 1977-08-01 1982-11-02 Northwestern University Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
DE2967069D1 (en) 1978-01-16 1984-08-02 Univ Boston Effecting cellular uptake of molecules
US4847240A (en) 1978-01-16 1989-07-11 The Trustees Of Boston University Method of effecting cellular uptake of molecules
US4701521A (en) 1978-07-17 1987-10-20 The Trustees Of Boston University Method of effecting cellular uptake of molecules
US4279996A (en) 1978-10-09 1981-07-21 Seiwa Kasei Co., Ltd. Keratin hydrolyzate useful as hair fixatives
GB2038628A (en) 1978-11-14 1980-07-30 Searle & Co Physiological compositions comprising poly(4-thiouridylic acid) or copolymers thereof and the use thereof as anti-viral agents or serum cholesterol lowering agents
US4356166A (en) 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
DE2945100A1 (de) 1979-11-08 1981-05-21 Henkel KGaA, 4000 Düsseldorf Neuartige tenside, deren herstellung und verwendung in hautfreundlichen spuel-, wasch- und reinigungsmitteln sowie enthaltende hautfreundliche, insbesondere kosmetische zubereitungen
JPS56163456A (en) 1980-05-21 1981-12-16 Otsuka Pharmaceut Co Ltd Preparation of antigen
US4284537A (en) 1980-07-03 1981-08-18 The United States Of America As Represented By The Department Of Health And Human Services Conjugate of streptococcal M protein peptide vaccine
US4369037A (en) 1980-11-19 1983-01-18 Kao Soap Co., Ltd. Hair treatment cosmetics containing cationic keratin derivatives
JPS57163318A (en) 1981-03-31 1982-10-07 Otsuka Pharmaceut Co Ltd Preparation of antigen
US4631190A (en) 1981-06-26 1986-12-23 Shen Wei C Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers
DE3150878A1 (de) 1981-12-22 1983-06-30 Boehringer Mannheim Gmbh, 6800 Mannheim "verfahren und reagenz zur bestimmung von creatinin"
US4532207A (en) 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
US4880911A (en) 1982-03-19 1989-11-14 G. D. Searle & Co. Fused polypeptides and methods for their detection
JP2519024B2 (ja) 1982-06-07 1996-07-31 花王株式会社 毛髪化粧料
JPS58225028A (ja) 1982-06-25 1983-12-27 Otsuka Pharmaceut Co Ltd ヒトα型インターフェロン抗体
US4728639A (en) 1982-07-27 1988-03-01 University Of Tennessee Research Corporation Type-specific opsonic antibodies evoked with a synthetic peptide of streptococcal M protein conjugated to polylysine without adjuvant
US4521334A (en) 1982-07-27 1985-06-04 The University Of Tennesse Research Corporation Synthetic polypeptide fragments
US4597967A (en) 1982-07-27 1986-07-01 The University Of Tennessee Research Corp. Synthetic polypeptide fragments
IT1212892B (it) 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
US5258041A (en) 1982-09-29 1993-11-02 Bio-Metric Systems, Inc. Method of biomolecule attachment to hydrophobic surfaces
EP0107053B1 (en) 1982-09-30 1989-09-13 Japanese Foundation For Cancer Research Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies
CA1249395A (en) 1982-09-30 1989-01-24 Tetsuya Tachikawa Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies
FR2540380B1 (fr) 1983-02-03 1986-02-07 Oreal Composition cosmetique pour la protection contre le rayonnement ultraviolet et son utilisation a cet effet
DE3470457D1 (en) 1983-02-25 1988-05-26 Kao Corp Hair cosmetics
JPS6043658A (ja) 1983-08-19 1985-03-08 Fuji Photo Film Co Ltd 銀塩拡散転写法写真受像要素
MX9203290A (es) 1983-09-19 1992-08-01 Liposome Co Inc Suministro localizado usando conjugados de fibronectina.
LU85067A1 (fr) 1983-10-28 1985-06-19 Oreal Composition et procede de traitement des matieres keratiniques avec au moins un polymere anionique et au moins une proteine quaternisee
US4671954A (en) 1983-12-13 1987-06-09 University Of Florida Microspheres for incorporation of therapeutic substances and methods of preparation thereof
US4534881A (en) 1983-12-19 1985-08-13 University Of South Alabama Inhibition of inorganic or biological CaCO3 deposition by poly amino acid derivatives
IT1180156B (it) 1984-01-09 1987-09-23 Crinos Industria Farmaco Composizione cosmetica a base di glicoproteine per il trattamento della pelle
US4568559A (en) 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
US4663286A (en) 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4744933A (en) 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
US4749620A (en) 1984-02-15 1988-06-07 Massachusetts Institute Of Technology Encapsulated active material system
US4695562A (en) 1984-04-06 1987-09-22 Univ. Of Tennessee Research Corp. Synthetic peptide compounds
FR2563431B1 (fr) 1984-04-26 1987-03-06 Roussel Uclaf Nouvelles compositions cosmetiques renfermant des extraits lyses d'hafnia
JPS6173665A (ja) 1984-09-20 1986-04-15 熊部　潔 人工皮膜による傷口の保護方法
US4834978A (en) 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
US5409904A (en) 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
GB8500121D0 (en) 1985-01-03 1985-02-13 Connaught Lab Microencapsulation of living cells
JPS61172807U (enExample) 1985-04-18 1986-10-27
JPS61243532A (ja) 1985-04-22 1986-10-29 Toshiba Corp 演算装置
DE3517205A1 (de) 1985-05-13 1986-11-13 Henkel KGaA, 4000 Düsseldorf Oligopeptid-derivate, deren herstellung und deren verwendung als hautfreundliche tenside
US5202431A (en) 1985-07-08 1993-04-13 Fidia, S.P.A. Partial esters of hyaluronic acid
JPH0338511Y2 (enExample) 1985-08-20 1991-08-14
JPS6248775A (ja) 1985-08-26 1987-03-03 Ishihara Sangyo Kaisha Ltd グラビアインキ組成物
US4645503A (en) 1985-08-27 1987-02-24 Orthomatrix Inc. Moldable bone-implant material
US4680338A (en) 1985-10-17 1987-07-14 Immunomedics, Inc. Bifunctional linker
SE8505921D0 (sv) 1985-12-13 1985-12-13 Kabigen Ab A method to export gene products to the growth medium of gram negative bacteria
US5955109A (en) 1985-12-18 1999-09-21 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of retinoic acid
US5145675A (en) 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
CH667874A5 (fr) 1985-12-19 1988-11-15 Battelle Memorial Institute Polypeptide synthetique biodegradable et son utilisation pour la preparation de medicaments.
GB8601100D0 (en) 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
US4741872A (en) 1986-05-16 1988-05-03 The University Of Kentucky Research Foundation Preparation of biodegradable microspheres useful as carriers for macromolecules
US5263992A (en) 1986-10-17 1993-11-23 Bio-Metric Systems, Inc. Biocompatible device with covalently bonded biocompatible agent
GB8630720D0 (en) 1986-12-23 1987-02-04 Unilever Plc Cosmetic compositions
EP0280155B1 (de) 1987-02-25 1992-05-20 Hoechst Aktiengesellschaft Mikroenkapsulierung von biologisch aktivem Material
JPH0665280B2 (ja) * 1987-03-04 1994-08-24 味の素株式会社 タンパクゲル化剤及びそれを用いるタンパクのゲル化方法
FR2612939B1 (fr) 1987-03-26 1989-06-23 Cird Equivalent de peau
JPS63253028A (ja) 1987-04-08 1988-10-20 Kao Corp 生体適合促進剤
US5166320A (en) 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
US5985354A (en) 1995-06-07 1999-11-16 Brown University Research Foundation Preparation of multiwall polymeric microcapsules from hydrophilic polymers
DE3851203T2 (de) 1987-05-11 1994-12-15 Procyte Corp Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums.
US5017229A (en) 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US6030958A (en) 1987-09-18 2000-02-29 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US6174999B1 (en) 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US6235726B1 (en) 1987-09-18 2001-05-22 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US4924624A (en) 1987-10-22 1990-05-15 Temple University-Of The Commonwealth System Of Higher Education 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof
US5763160A (en) 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
US5506126A (en) 1988-02-25 1996-04-09 The General Hospital Corporation Rapid immunoselection cloning method
US5851527A (en) 1988-04-18 1998-12-22 Immunomedics, Inc. Method for antibody targeting of therapeutic agents
US5510329A (en) 1988-04-26 1996-04-23 Ramot University For Applied Research And Industrial Development Ltd. Preparations for the treatment of eyes
US4879116A (en) 1988-06-13 1989-11-07 Charles Fox Skin protein complexing composition for the potentiation of the substantivity of aluminum acetate through the use of a cationic emulsifier as an aid in skin healing
CA1308022C (en) 1988-08-11 1992-09-29 Eleftherios P. Diamandis Multiple fluorescence labelling with europium chelators
US4908404A (en) 1988-08-22 1990-03-13 Biopolymers, Inc. Synthetic amino acid-and/or peptide-containing graft copolymers
US5840293A (en) 1988-11-16 1998-11-24 Advanced Polymer Systems, Inc. Ionic beads for controlled release and adsorption
US5470829A (en) 1988-11-17 1995-11-28 Prisell; Per Pharmaceutical preparation
CA2006060A1 (en) 1988-12-20 1990-06-20 Michael D. Pierschbacher Polypeptide-polymer conjugates active in wound healing
JPH02169511A (ja) 1988-12-21 1990-06-29 Kanebo Ltd 皮膚化粧料
US5175112A (en) 1989-01-20 1992-12-29 Diagnostica Stago Submicron particles, preparation and utilization in immunodiagnosis
JP2719166B2 (ja) 1989-02-02 1998-02-25 鐘紡株式会社 毛髪化粧料組成物
US5783691A (en) 1989-02-08 1998-07-21 Biomatrix, Inc. Crosslinked hyaluronate gels, their use and method for producing them
US5098833A (en) 1989-02-23 1992-03-24 Genentech, Inc. DNA sequence encoding a functional domain of a lymphocyte homing receptor
US5354844A (en) 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US6007816A (en) 1989-03-17 1999-12-28 Fred Hutchinson Cancer Research Center Methods of using CD44-specific antibodies
FR2645741B1 (fr) 1989-03-20 1995-06-23 Dior Christian Parfums Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation
US5132230A (en) 1989-03-28 1992-07-21 Isolab, Inc. Primary standard and method of making secondary standards for calibration of glycated protein assays
AU628988B2 (en) 1989-05-04 1992-09-24 Wisconsin Alumni Research Foundation Method for localization and treatment of tumors and complexes therefor
US4973473A (en) 1989-06-23 1990-11-27 Revlon, Inc. Skin care preparation
US5091173A (en) 1989-06-29 1992-02-25 The University Of Dundee Hair growth composition
IT1230297B (it) 1989-07-05 1991-10-18 Carmelo Lo Duca Siringa utilizzabile una sola volta.
FR2649888B1 (fr) 1989-07-18 1994-08-26 Exsymol Sa Produits pour applications cutanees, a effets cosmetiques ou/et therapeutiques
US6271216B1 (en) 1989-07-24 2001-08-07 Allergan Stable solution of hyaluronate in a balanced salt medium
JPH0383908A (ja) 1989-08-28 1991-04-09 Kanebo Ltd 皮膚化粧料
US5162505A (en) 1989-09-19 1992-11-10 Centocor Proteins modified with positively charged carriers and compositions prepared therefrom
CA1340994C (en) 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5461081A (en) 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
JPH03123861A (ja) 1989-10-06 1991-05-27 Mitsubishi Kasei Corp ハプテンの免疫化学的測定法
DE69033199T2 (de) 1989-10-31 1999-10-28 Columbia Lab Bermuda Ltd Mittel zur feuchthaltung von gewebe und verfahren
AU642932B2 (en) 1989-11-06 1993-11-04 Alkermes Controlled Therapeutics, Inc. Protein microspheres and methods of using them
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
US5075019A (en) 1989-12-14 1991-12-24 Exxon Chemical Patents Inc. Low sediment method for preparing copper salts of polyolefinic-substituted dicarboxylic acids
DK0506884T3 (da) 1989-12-21 1996-11-04 Whitehead Biomedical Inst Fremgangsmåde til afgivelse af molekyler til eukaryotiske celler
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5660851A (en) 1989-12-26 1997-08-26 Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem Ocular inserts
DE4004430A1 (de) 1990-02-09 1991-08-14 Schering Ag Aus polyaldehyden aufgebaute kontrastmittel
FR2658719B1 (fr) 1990-02-28 1992-05-15 Oreal Utilisation en association, dans la preparation de compositions cosmetiques sous forme de poudres compactees, de microspheres creuses en materiau synthetique thermoplastique, de nitrure de bore hexagonal, et de n-acyl lysine.
IL97350A (en) 1990-03-09 1995-05-26 Ciba Geigy Hybridomas that produce metaccharide-specific tribal antibodies, and their use in metachlorological immunological regularity
JP2897780B2 (ja) 1990-03-09 1999-05-31 ニッピゼラチン工業株式会社 高重合ゼラチンの製造法
FR2660556B1 (fr) 1990-04-06 1994-09-16 Rhone Poulenc Sante Microspheres, leur procede de preparation et leur utilisation.
JPH05508398A (ja) 1990-05-11 1993-11-25 ザ ユニバーシティ オブ コネチカット 細胞毒からの標的保護
US5100956A (en) 1990-06-27 1992-03-31 Siltech Inc. Silicone protein polymers
CA2061566C (en) 1992-02-20 2002-07-09 Rudolf E. Falk Treatment of disease employing hyaluronic acid and nsaids
US5149543A (en) 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
US5232984A (en) 1990-10-15 1993-08-03 The Board Of The Regents The University Of Texas Biocompatible microcapsules
US5380536A (en) 1990-10-15 1995-01-10 The Board Of Regents, The University Of Texas System Biocompatible microcapsules
US5462990A (en) 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
DE69116495T2 (de) 1990-10-19 1996-06-13 Ajinomoto Kk Rekombinante Transglutaminase
US5633230A (en) 1990-10-24 1997-05-27 Allelix Biopharmaceuticals, Inc. Treatment of cytomegalovirus infection
US5646120A (en) 1990-10-24 1997-07-08 Allelix Biopharmaceuticals, Inc. Peptide-based inhibitors of HIV replication
US5674849A (en) 1990-10-24 1997-10-07 Allelix Biopharmaceuticals Inc. Anti-viral compositions
ES2095959T3 (es) 1990-10-24 1997-03-01 Allelix Biopharma Inhibidores de la replicacion del virus vih a base de peptidos.
US5831001A (en) 1990-10-24 1998-11-03 Allelix Biopharmaceuticals Inc. Treatment of herpesvirus infection
AU655445B2 (en) 1990-11-29 1994-12-22 Iatron Laboratories, Inc. Polyelectrolyte complex antibacterial agent and antibacterial material
AU1268192A (en) 1991-01-04 1992-08-17 Board Of Regents, The University Of Texas System Cloning and expression of tissue transglutaminases
CA2060223C (en) 1991-02-12 1999-07-20 Clarence C. Lee Injectable medical lubricating fluid composition and method of use
US5993805A (en) 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
IT1247175B (it) 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
JP4162259B2 (ja) 1991-04-26 2008-10-08 ビオメリュー・ソシエテ・アノニム リウマチ性関節炎抗体により認識される抗原、抗原製剤及びその適用方法
DE4115789A1 (de) 1991-05-10 1992-11-12 Schering Ag Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5846951A (en) 1991-06-06 1998-12-08 The School Of Pharmacy, University Of London Pharmaceutical compositions
US5990095A (en) 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5817644A (en) 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
US6022866A (en) 1991-07-03 2000-02-08 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5834444A (en) 1991-07-03 1998-11-10 Hyal Pharmaceutical Corporation Hyaluronic acid and salts thereof inhibit arterial restenosis
US5246780A (en) 1991-08-29 1993-09-21 L'oreal Coated particle for use in cosmetic preparations and method
US6030954A (en) 1991-09-05 2000-02-29 University Of Connecticut Targeted delivery of poly- or oligonucleotides to cells
JPH07500820A (ja) 1991-09-05 1995-01-26 ユニバーシティ オブ コネティカット ポリヌクレオチド又はオリゴヌクレオチドの細胞への標的を定めた送達
NZ244306A (en) 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
US5521291A (en) 1991-09-30 1996-05-28 Boehringer Ingelheim International, Gmbh Conjugates for introducing nucleic acid into higher eucaryotic cells
AU651249B2 (en) 1991-10-01 1994-07-14 Alain Ladislas De Weck Method for the determination of sulfidoleukotrienes in tissues and biological fluids and its application in diagnosis of allergies and other inflammatory diseases
WO1993009176A2 (en) 1991-10-29 1993-05-13 Clover Consolidated, Limited Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5922859A (en) 1992-02-01 1999-07-13 Boehringer Ingelheim International Gmbh Complexes containing nucleic acid which can be taken-up by endocytosis into higher eukaryotic cells
GB9202464D0 (en) 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
US6136793A (en) 1992-02-20 2000-10-24 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5573934A (en) 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
DE4208645A1 (de) 1992-03-18 1993-09-23 Bayer Ag Optischer festphasenbiosensor auf basis fluoreszenzfarbstoffmarkierter polyionischer schichten
US5578442A (en) 1992-03-23 1996-11-26 Vivorx, Inc. Graft copolymers of polycationic species and water-soluble polymers, and use therefor
US5334640A (en) 1992-04-08 1994-08-02 Clover Consolidated, Ltd. Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods
US5614212A (en) 1992-04-08 1997-03-25 International Medical Associates, Inc. Method of transdermally administering high molecular weight drugs with a polymer skin enhancer
CA2094658A1 (en) 1992-04-23 1993-10-24 Martin Sumner-Smith Intracellular delivery of biochemical agents
DE69320469D1 (de) 1992-04-23 1998-09-24 Allelix Biopharma Behandlung von herpesvirus infektion
US6235313B1 (en) 1992-04-24 2001-05-22 Brown University Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
US5902795A (en) 1992-06-16 1999-05-11 Trustees Of Tufts College Oligosaccharides reactive with hyaluronan-binding protein and their methods of use
US5595893A (en) 1992-06-19 1997-01-21 Iowa State University Research Foundation, Inc. Immobilization of microorganisms on a support made of synthetic polymer and plant material
US5436291A (en) 1992-07-09 1995-07-25 University Of Michigan, The Board Of . . . Calcification-resistant synthetic biomaterials
GB9215780D0 (en) 1992-07-24 1992-09-09 Univ London Pharmacy Peptide compounds
US5871710A (en) 1992-09-04 1999-02-16 The General Hospital Corporation Graft co-polymer adducts of platinum (II) compounds
JPH08501097A (ja) 1992-09-04 1996-02-06 ザ ゼネラル ホスピタル コーポレーション 臨床診断及び治療用部分を含む生体適合性ポリマー
FR2695558B1 (fr) 1992-09-11 1994-10-21 Oreal Composition cosmétique contenant des particules solides revêtues avec un polymère amphotère.
US5656609A (en) 1992-09-24 1997-08-12 University Of Connecticut Method of enhancing and/or prolonging expression of gene introduced into a cell using colchicine
US5358706A (en) 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
EP0599303A3 (en) 1992-11-27 1998-07-29 Takeda Chemical Industries, Ltd. Peptide conjugate
EP0601417A3 (de) 1992-12-11 1998-07-01 Hoechst Aktiengesellschaft Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung
WO1994014464A1 (en) 1992-12-22 1994-07-07 Allelix Biopharmaceuticals Inc. Synergistic compositions containing an antiviral nucleoside analogue and an antiviral oligopeptide
US5861156A (en) 1993-01-08 1999-01-19 Creative Biomolecules Methods of delivering agents to target cells
EP0608117A3 (en) 1993-01-20 1996-01-17 Ono Pharmaceutical Co Antibodies for mevalonic acid and methods for determination of mevalonic acid.
BR9405664A (pt) 1993-01-21 1996-04-30 Univ Georgia Composto imunogenio processos para evitar a toxicose por festuca em um herbivoro para tratar a toxicose por festuca em um herbivoro anticorpo purificado lingagem de célula de hidridoma e anticorpo
US5674977A (en) 1993-02-05 1997-10-07 The Ontario Cancer Institute Branched synthetic peptide conjugate
AU6254494A (en) 1993-02-16 1994-09-14 Virginia Tech Intellectual Properties, Inc. Polyelectrolyte dna conjugation and genetic transformation of an animal
DE69310339T2 (de) 1993-02-19 1997-08-21 Philippe Djian Präparate, die Corneozyt Proteine enthalten
WO1994020512A2 (en) 1993-03-01 1994-09-15 Glycan Pharmaceuticals, Inc. Analogs for specific oligosaccharide-protein interactions and uses therefor
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
DE4311651A1 (de) 1993-04-08 1994-10-13 Boehringer Ingelheim Int Virus für den Transport von Fremd-DNA in höhere eukaryotische Zellen
CA2160878A1 (en) 1993-04-19 1994-10-27 Sandra Gertrude Mcelligott Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression
US5548064A (en) 1993-05-24 1996-08-20 Biotech Australia Pty Limited Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions
US5981252A (en) 1993-06-25 1999-11-09 Smithkline Beecham Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
US5661040A (en) 1993-07-13 1997-08-26 Abbott Laboratories Fluorescent polymer labeled conjugates and intermediates
US5534241A (en) 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
GB2282384B8 (en) 1993-08-18 1997-09-04 Europ Economic Community Drug delivery agents incorporating mitomycin
BE1007422A3 (nl) 1993-08-23 1995-06-13 Dsm Nv Werkwijze voor de bereiding van een mengsel van penteenzure alkylesters.
US5635385A (en) 1993-09-15 1997-06-03 Temple University-Of The Commonwealth System Of Higher Education Multi-unit ribozyme inhibition of oncogene gene expression
EP0727223B1 (en) 1993-09-28 2001-11-28 Hisamitsu Pharmaceutical Co., Inc. Polyamino acid oligonucleotide carrier
DE4335025A1 (de) 1993-10-14 1995-04-20 Boehringer Ingelheim Int Endosomolytisch wirksame Partikel
RU2025487C1 (ru) 1993-10-18 1994-12-30 Товарищество с ограниченной ответственностью "БиоПрогресс" Способ направленной генетической трансформации молочной железы животного и устройство для введения генетического материала в молочный проток молочной железы животного
WO1995011038A1 (en) 1993-10-22 1995-04-27 Allelix Biopharmaceuticals Inc. Treatment of cytomegalovirus infection
CA2155929A1 (en) 1993-12-14 1995-06-22 Christopher H. Evans Systemic gene treatment of connective tissue diseases
US5635380A (en) 1994-01-18 1997-06-03 Vanderbilt University Enhancement of nucleic acid transfer by coupling virus to nucleic acid via lipids
FR2715847B1 (fr) 1994-02-08 1996-04-12 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
US5773577A (en) 1994-03-03 1998-06-30 Protein Polymer Technologies Products comprising substrates capable of enzymatic cross-linking
US6037329A (en) 1994-03-15 2000-03-14 Selective Genetics, Inc. Compositions containing nucleic acids and ligands for therapeutic treatment
WO1995024929A2 (en) 1994-03-15 1995-09-21 Brown University Research Foundation Polymeric gene delivery system
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US5863724A (en) 1994-04-13 1999-01-26 Baylor College Of Medicine Methods of screening for persistent hyperinsulinemic hypoglycemia of infancy
US5505952A (en) 1994-04-19 1996-04-09 United States Surgical Corporation Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom
FR2719316B1 (fr) 1994-04-28 1996-05-31 Idm Nouveaux complexes d'acide nucléique et de polymère, leur procédé de préparation et leur utilisation pour la transfection de cellules.
EP0712635B1 (en) 1994-05-13 2003-05-02 Kuraray Co., Ltd. Medical polymer gel
DE4418965A1 (de) 1994-05-31 1995-12-07 Boehringer Ingelheim Int Verfahren zum Einbringen von Nukleinsäure in höhere eukaryotische Zellen
AU2946295A (en) 1994-06-27 1996-01-19 Johns Hopkins University, The Targeted gene delivery system
US5670558A (en) 1994-07-07 1997-09-23 Terumo Kabushiki Kaisha Medical instruments that exhibit surface lubricity when wetted
IT1273011B (it) 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
IT1273742B (it) 1994-08-01 1997-07-09 Lifegroup Spa Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
US5716614A (en) 1994-08-05 1998-02-10 Molecular/Structural Biotechnologies, Inc. Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
US5681568A (en) 1994-08-19 1997-10-28 Cambridge Neuroscience, Inc. Device for delivery of substances and methods of use thereof
DE4430601A1 (de) 1994-08-22 1996-02-29 Beiersdorf Ag Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander
US5490980A (en) 1994-09-28 1996-02-13 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Covalent bonding of active agents to skin, hair or nails
US5837533A (en) 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
JPH0889278A (ja) 1994-09-29 1996-04-09 Ajinomoto Co Inc 遺伝子導入用修飾蛋白質及びその製法
FR2725369B1 (fr) 1994-10-07 1997-01-03 Oreal Composition cosmetique ou dermatologique constituee d'une emulsion huile dans eau a base de globules huileux pourvus d'un enrobage cristal liquide lamellaire
US5620013A (en) 1994-10-21 1997-04-15 American Cyanamid Company Method for destroying residual lens epithelial cells
US5668210A (en) 1994-10-24 1997-09-16 The Dow Chemical Company Adhesion promoter and self-priming arylcyclobutene resin compositions
US5639712A (en) 1994-11-04 1997-06-17 Indiana University Foundation Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US5783178A (en) 1994-11-18 1998-07-21 Supratek Pharma. Inc. Polymer linked biological agents
FR2728165A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
US5677276A (en) 1994-12-23 1997-10-14 La Jolla Cancer Research Foundation Immobilization of peptides to hyaluronate
AU4690596A (en) 1994-12-30 1996-07-24 Chiron Viagene, Inc. Nucleic acid condensing agents with reduced immunogenicity
FR2729946A1 (fr) 1995-01-31 1996-08-02 Oreal Nouveaux derives de lysine, procede de preparation, utilisations et compositions les comprenant
US5629021A (en) 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
JPH10513378A (ja) 1995-02-07 1998-12-22 フィディア・アドバンスト・バイオポリマーズ・ソシエタ・ア・レスポンサビリタ・リミタータ ヒアルロン酸、その誘導体、および半合成ポリマーで物体を被覆する方法
US5916790A (en) 1995-03-03 1999-06-29 Metabolex, Inc. Encapsulation compositions, and methods
US5587301A (en) 1995-03-10 1996-12-24 Incyte Pharmaceuticals, Inc. DNA encoding a hyaluronan receptor expressed in human umbilical vein endothelial cells
US5686113A (en) 1995-03-21 1997-11-11 Temple University Of The Commonwealth System Of Higher Education Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses
FR2732220B1 (fr) 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour traiter les lichens et les prurits et composition obtenue
US5811510A (en) 1995-04-14 1998-09-22 General Hospital Corporation Biodegradable polyacetal polymers and methods for their formation and use
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
US5612027A (en) 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
US5788959A (en) 1995-04-24 1998-08-04 University Of Maryland, Baltimore County Drug delivery device and method for employing the same
IT1281870B1 (it) 1995-04-27 1998-03-03 Fidia Advanced Biopolymers Srl Pelle artificiale umana costituita da materiali biocompatibili a base di derivati dell'acido ialuronico
US5968542A (en) 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
FR2736042B1 (fr) 1995-06-30 1997-09-12 Rhone Poulenc Chimie Dispersion colloidale et composition redispersible sous forme d'une dispersion colloidale a base d'oxyde de cerium
CA2154103C (en) 1995-07-18 1998-02-24 Samuel Simon Asculai Treatment of mucous membrane disease, trauma or condition and for the relief of pain
EP0851768B1 (en) 1995-09-01 2002-04-24 University of Washington Interactive molecular conjugates
WO1997011710A1 (en) 1995-09-28 1997-04-03 Sangstat Medical Corporation Use of hyaluronic acid as an immunosuppressant
US6573296B2 (en) 1995-11-03 2003-06-03 Advanced Research And Technology Institute, Inc. Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
US5723301A (en) 1995-11-03 1998-03-03 Duke University Method to screen compounds that affect GAPDH binding to polyglutamine
JP3059092B2 (ja) 1995-11-15 2000-07-04 田辺製薬株式会社 ドライアイおよびドライアイを原因とする疾患の予防・治療剤
EP1704878B1 (en) 1995-12-18 2013-04-10 AngioDevice International GmbH Crosslinked polymer compositions and methods for their use
US6132462A (en) 1995-12-22 2000-10-17 Santen Pharmaceutical Co., Ltd. Copolymers formed from three components and intraocular lenses made thereof
US5968543A (en) 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
US5780054A (en) 1996-01-17 1998-07-14 University Of British Columbia Methods for increasing the circulation half-life of protein-based therapeutics
US5985312A (en) 1996-01-26 1999-11-16 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US6368586B1 (en) 1996-01-26 2002-04-09 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US5785977A (en) 1996-02-07 1998-07-28 Breithbarth; Richard Non-metallic microparticle carrier materials
US6280745B1 (en) 1997-12-23 2001-08-28 Alliance Pharmaceutical Corp. Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
US5842477A (en) 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
US5843770A (en) 1996-03-11 1998-12-01 The Immune Response Corporation Antisense constructs directed against viral post-transcriptional regulatory sequences
AU735900B2 (en) 1996-03-12 2001-07-19 Pg-Txl Company, L.P. Water soluble paclitaxel prodrugs
JP2000506865A (ja) 1996-03-14 2000-06-06 ジ イミューン リスポンス コーポレイション インターフェロンをコードする遺伝子の標的を定めた送達
US5646133A (en) 1996-03-14 1997-07-08 Donlar Corporation Polyaspartic acid and its analogues in combination with insecticides
US5783566A (en) 1996-05-10 1998-07-21 California Institute Of Technology Method for increasing or decreasing transfection efficiency
US5635447A (en) 1996-03-22 1997-06-03 Donlar Corporation Polyorganic acids and their analogues to enhance herbicide effectiveness
DE69737828T2 (de) 1996-04-29 2008-03-06 Novozymes A/S Flüssige, nichtwässrige enzyme enthaltende zusammensetzungen
ATE345682T1 (de) 1996-05-01 2006-12-15 Imarx Pharmaceutical Corp In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
JP2000509394A (ja) 1996-05-01 2000-07-25 アンティバイラルズ インコーポレイテッド 細胞膜を横切って物質を輸送するためのポリペプチド結合体
US20020016304A1 (en) 1996-05-16 2002-02-07 Atsushi Maruyama Carrier for stabilizing nucleic acid
IT1282734B1 (it) 1996-05-20 1998-03-31 Istituto Biochimico Italiano Oligonucleotidi antisenso di sequenza complementare al trascritto primario del protooncogene umano c-fes e loro uso in combinazione
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
EP0907721A1 (en) 1996-05-28 1999-04-14 Brown University Research Foundation Hyaluronan based biodegradable scaffolds for tissue repair
US5965532A (en) 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
EP0920339A2 (en) 1996-07-09 1999-06-09 The Johns Hopkins University Gene delivery system
US5945100A (en) 1996-07-31 1999-08-31 Fbp Corporation Tumor delivery vehicles
US5851229A (en) 1996-09-13 1998-12-22 Meadox Medicals, Inc. Bioresorbable sealants for porous vascular grafts
US5913884A (en) 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
JP2000500879A (ja) 1996-09-20 2000-01-25 アセロジエニクス・インコーポレイテツド 炎症性疾患の診断及びメディエータ
EP0950665A4 (en) 1996-09-26 2004-05-06 Ajinomoto Kk PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
US5980883A (en) 1996-10-02 1999-11-09 Kuraray Co., Ltd. Polymer gel for medical use
US6103525A (en) 1996-10-17 2000-08-15 The Regents Of The University Of California Hybridoma cell lines producing monoclonal antibodies that bind to human plasma hyaluronidase
US6331289B1 (en) 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors
US5993856A (en) 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
AU6163398A (en) 1997-02-11 1998-08-26 Merck & Co., Inc. Identification of inhibitors of protein tyrosine kinase 2
BR9807365A (pt) 1997-02-13 2002-02-05 Bausch & Lomb Surgical Inc Composição para destruir células epiteliais de pigmento retinal e células proliferativas
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US6281341B1 (en) 1997-04-30 2001-08-28 Biomm, Inc. & University Of Miami Hetero-polysaccharide conjugate and methods of making and using the same
US5962015A (en) 1997-05-02 1999-10-05 Kobo Products S.A.R.L. Stabilized liposomes
AU734827B2 (en) 1997-05-21 2001-06-21 Board Of Trustees Of The Leland Stanford Junior University Composition and method for enhancing transport across biological membranes
US5885609A (en) 1997-05-23 1999-03-23 Northeastern University Biocompatible articles and method for making same
US6150461A (en) 1997-05-27 2000-11-21 Hisamitsu Pharmaceutical Co., Inc. Carriers targettable to organ
US5861149A (en) 1997-06-04 1999-01-19 Polyheal Ltd. Methods for wound treatment
ES2296336T3 (es) 1997-06-25 2008-04-16 Novozymes A/S Polipeptido modificado.
AU738494B2 (en) 1997-07-10 2001-09-20 Salk Institute For Biological Studies, The Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression
AU735170B2 (en) 1997-07-21 2001-07-05 Board Of Trustees Of The University Of Illinois, The Modifying tissue surfaces by liquid crystal formation
US6280938B1 (en) 1997-08-19 2001-08-28 Regents Of The University Of Minnesota SCA7 gene and method of use
AUPO888097A0 (en) 1997-08-29 1997-09-25 Biotech Australia Pty Limited Cross-linked particles
US6054312A (en) 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
US6229009B1 (en) 1997-08-29 2001-05-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Polycarboxylic based cross-linked copolymers
US6045835A (en) 1997-10-08 2000-04-04 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
IL122153A (en) 1997-11-10 2005-03-20 Alomone Labs Ltd Biocompatible polymeric coating material
US6251392B1 (en) 1997-10-20 2001-06-26 Epicyte Pharmaceuticals, Inc. Epithelial cell targeting agent
CA2237051A1 (en) 1997-12-19 1999-06-19 Eva A. Turley Enhanced affinity hyaluronan binding peptides
US6958148B1 (en) * 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
WO1999036570A2 (en) 1998-01-20 1999-07-22 Pericor Science Inc Transglutaminase linkage of agents to tissue
US6919076B1 (en) * 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
JP3012923B2 (ja) 1998-01-26 2000-02-28 新潟大学長 Ｃａｇリピート病の治療薬
US6378527B1 (en) 1998-04-08 2002-04-30 Chondros, Inc. Cell-culture and polymer constructs
US6200595B1 (en) 1998-04-24 2001-03-13 Kuraray Co., Ltd. Medical adhesive
US5962018A (en) 1998-04-28 1999-10-05 Avon Products, Inc. Method of treating the skin with organic acids in anhydrous microsphere delivery systems
US5939453A (en) 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US6177259B1 (en) 1998-08-07 2001-01-23 President And Fellows Of Harvard College Assays and kits for inhibition of polyglutamine-induced cell death
JP3524401B2 (ja) 1998-09-16 2004-05-10 株式会社ニチレイ 酵素抗体複合体およびその製造方法
CA2246664A1 (en) 1998-10-02 2000-04-02 Universite Paris 7 Vascular specific regulatory elements contained in the desmin 5' flanking region
AU759016B2 (en) 1998-10-05 2003-04-03 Penn State Research Foundation, The Compositions and methods for enhancing receptor-mediated cellular internalization
US6251599B1 (en) 1998-11-06 2001-06-26 Selective Genetics, Inc. Stabilized nucleic acid compositions and methods of preparation and use thereof
US6395029B1 (en) 1999-01-19 2002-05-28 The Children's Hospital Of Philadelphia Sustained delivery of polyionic bioactive agents
EP1156809B1 (en) 1999-03-01 2005-12-07 Vista Scientific LLC Mucin containing ophthalmic preparations
US6107326A (en) 1999-04-12 2000-08-22 Cytopharm, Inc. Porphycenes for treatment of microbial populations
EP1067174B1 (en) 1999-07-08 2004-09-29 The Procter & Gamble Company Process for producing particles of amine reaction product
EP1067173A1 (en) 1999-07-08 2001-01-10 The Procter & Gamble Company Process for producing particles of amine reaction product
EP1067116A1 (en) 1999-07-09 2001-01-10 The Procter & Gamble Company Process for the production of imines
EP1067117A1 (en) 1999-07-09 2001-01-10 The Procter & Gamble Company Process for making imine compounds
WO2001007009A1 (en) 1999-07-22 2001-02-01 Pericor Science, Inc. Lysine oxidase linkage of agents to tissue
EP1203141A1 (en) 1999-07-22 2002-05-08 Pericor Science, Inc. Linkage of agents to tissue
MXPA02001857A (es) 1999-08-24 2003-07-14 Cellgate Inc Composiciones y metodos para incrementar la entrega de drogas a traves y dentro de tejidos epiteliales.
WO2001032850A1 (en) 1999-10-29 2001-05-10 Min Hu Surface treatment with polypeptides to improve fibroblast adhesion to hyaluronan
BR0015416A (pt) 1999-11-09 2002-07-16 Alcon Inc Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
US20020009491A1 (en) 2000-02-14 2002-01-24 Rothbard Jonathan B. Compositions and methods for enhancing drug delivery across biological membranes and tissues
US6348508B1 (en) 2000-04-04 2002-02-19 Bausch & Lomb Incorporated Method for treating dry eye

Also Published As

Publication number Publication date
JP2004504340A (ja) 2004-02-12
WO2002007707A3 (en) 2002-08-15
EP1303260A2 (en) 2003-04-23
AU2002224524A1 (en) 2002-02-05
US20060110379A1 (en) 2006-05-25
US6958148B1 (en) 2005-10-25
WO2002007707A2 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
US6958148B1 (en) Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) Conjugates of agents and transglutaminase substrate linking molecules
EP1202706A1 (en) Lysine oxidase linkage of agents to tissue
EP1203141A1 (en) Linkage of agents to tissue
US6267957B1 (en) Attaching agents to tissue with transglutaminase and a transglutaminase substrate
US12350352B2 (en) Composition for surface modification
JP2005513007A (ja) 特定の浸透圧保護剤によって安定化させた酵素を含有する組成物、及びパーソナルケアにおける前記組成物の使用方法
JP2024019506A (ja) 化粧料
JP2021521167A (ja) 毛髪改質組成物およびその方法
JP6930990B2 (ja) シロキサン組成物
EP2097059B1 (de) Reinigungs- oder pflegeprodukt
JP2005515180A (ja) 阻害物質で安定化させた酵素を含有する局所適用組成物
AU2004249165A1 (en) Modified soy proteins in skin tightening compositions
JP6773799B2 (ja) 組成物及び調製方法
BR112020005529A2 (pt) método para tingir cabelo
JP2021531251A (ja) グリセロール誘導体および二還式化合物を含む、抗菌性の組み合わせ組成物
JP2019529670A (ja) シリコーン樹脂−直鎖状コポリマー及び関連する方法
KR102083325B1 (ko) 피부 미백용 화장료 조성물
JP2022000414A (ja) イヌリン及び多価アルコールを含有する化粧料又は皮膚外用剤
KR20170062957A (ko) 피부 미백용 화장료 조성물
CN120187292A (zh) 抗微生物组合物
JP2024083004A (ja) 皮膚外用組成物、
KR20170036276A (ko) 피부 미백용 화장료 조성물
KR20170060429A (ko) 피부 미백용 화장료 조성물
CN119584861A (zh) 抗微生物组合

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued